zenocutuzumab
merus
['zenocutuzumab']
 giving an update on the phase 1/2 enrgy trial of zenocutuzumab in nrg1+ cancers at the bispecifics clinical science symposium at #asco22 - read more on zeno in : 
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Tweets are my own. She/her